In summary, our findings support a close association between inhibited nuclear entry of HLH-30/TFEB and autophagy dysfunction in AD and indicate that identifying TFEB-specific activators is a promising strategy for treating AD. The gene discussed is TFEB; the disease is Alzheimer disease.